Literature DB >> 27620711

Head and neck cancer: Gemcitabine improves patient survival.

Peter Sidaway.   

Abstract

Entities:  

Year:  2016        PMID： 27620711     DOI： 10.1038/nrclinonc.2016.149

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.

Authors:  Li Zhang; Yan Huang; Shaodong Hong; Yunpeng Yang; Gengsheng Yu; Jun Jia; Peijian Peng; Xuan Wu; Qing Lin; Xuping Xi; Jiewen Peng; Mingjun Xu; Dongping Chen; Xiaojun Lu; Rensheng Wang; Xiaolong Cao; Xiaozhong Chen; Zhixiong Lin; Jianping Xiong; Qin Lin; Conghua Xie; Zhihua Li; Jianji Pan; Jingao Li; Shixiu Wu; Yingni Lian; Quanlie Yang; Chong Zhao
Journal:  Lancet       Date:  2016-08-23       Impact factor: 79.321
  1 in total
  1 in total

1.  Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells.

Authors:  Chieh-Yu Lan; Sheng-Yi Chen; Chia-Wen Kuo; Chi-Cheng Lu; Gow-Chin Yen
Journal:  J Food Drug Anal       Date:  2019-08-21       Impact factor: 6.157
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.